** Shares of vaccine maker Moderna MRNA.O rise 9.2% to $33.19 premarket
** CEO Stephane Bancel has bought ~160,000 MRNA shares at roughly $31/shr, SEC filing showed late Tuesday
** MRNA shares have fallen 39.1% since mid-January, when co cut 2025 sales forecast by $1 bln
** Co has ~385 million outstanding shares, as of February 14
** Stock fell 68.3% in past 12 months
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。